RA 10918 Exam Questions And Answers – Latest Updated 2024/2025 (GRADED A+)
RA 10918 Exam Questions And Answers – Latest Updated 2024/2025 (GRADED A+)RA 10918 - Answer An act regulating and modernizing the practice of pharmacy in the Philippines, repealing for the purpose of RA 5921 known as Pharmacy Law RA 10918 Title - Answer Philippine Pharmacy Act Statement of Policy 10918 - Answer Recognize vital role of pharmacies in the delivery of quality healthcare services through provision of safe, effective and quality pharmaceutical products, etc. Statement of Policy 10918 - Answer Pharmacists professional services promoted as indispensable component of the total health care system to ensure physical wellbeing of Pinoys Statement of Policy 10918 - Answer State shall develop and nurture competent, productive, etc. whose standards of practice are globally competitive Objectives 10918 - Answer 1. Standardization and regulation of pharmacy education 2. Administration of licensure examination, reg. and licensing of pharmacists 3. Supervision, control and regulation of pharmacy practice in PH Objectives 10918 - Answer 1. Devt and enhancement of professional competence of RPhs through CPD, rsch. Etc 2. Integration of Pharmacy profession Activities exclusive to licensed RPhs - Answer 1. Prepare, manuf, compound, etc. pharmaceutical product and its raw mats 2. Render services like ClinPhar, DI etc. when expertise of RPh is required 3. Provide services where pharmaceutical knowledge is required Activities exclusive to licensed RPhs - Answer 1. 1. Engage in teaching scientific, technical or professional pharmacy courses in school of pharmacy 2. Dispense pharmaceutical products where supervision of dispensing is required Activities non-exclusive to licensed RPhs 1. Chemical, biological and microbiological analyses and assay of pharmaceutical prods, etc. 2. Physico-chem analyses for med devices used in aid of pharmprod admin - Answer RA 10918 Exam Questions And Answers – Latest Updated 2024/2025 (GRADED A+) Activities non-exclusive to licensed RPhs - Answer 1. Administration of adult vaccines provided they undergo training for mgt of AEFI 2. Conduct scientific rsch in all aspects involving pharm prods or health care All RPh are expected to abide to this - Answer Philippine Practice Standard for Pharmacists, GLP, GDP, GCP, GMP APO - Answer may modify the standards of pharmacy provided modifications are consistent Accredited Professional Organization - Answer Duly accredited professional organization of pharmacists, of which there shall be only one, as prescribed under Sec. 41 Article V of the Act Adulterated/Deteriorated Pharmaceutical Products - Answer Pharmaceutical products unfit for human consumption, following the standards of quality or purity of which, are as those stated in the USP/NF in its latest edition or any standard reference for drugs and medicines Adult vaccines - Answer Refer to cervical cancer, flu (influenza), pneumococcal, other pre-exposure prophylactic vaccines to be administered to patients aged eighteen (18) years and above, and such other vaccines as may be defined by the DOH in an administrative issuance Adverse Drug Reaction - Answer Noxious and unintended reaction to a drug which occurs at doses normally used in human for the prophylaxis, diagnosis or treatment of disease or for the modification of physiologic function Biopharmaceuticals - Answer In-vivo diagnostic purposes, such as vaccines, sera, and drugs derived from life forms using biotechnology Biopharmaceuticals - Answer Proteins, nucleic acids, or living microorganisms where the virulence is reduced and are used for therapeutic or in vivo diagnostic purposes Brand Name - Answer Proprietary name given by the manufacture Cipher, Code, or Secret Key - Answer Method of secret writing Clinical Pharmacy Services - Answer Promote the appropriate selection and utilization of medication to optimize individualized therapeutic outcomes, achieve wellness or prevent disease Clinical Pharmacy Services - Answer Pharmacologic and non- pharmacologic strategies Compounding - Answer Sum of processes performed by a pharmacist in drug preparation Compounding - Answer Calculations, mixing, assembling, packaging, or labelling of a drug Continuing Professional Development (CPD) - Answer Inculcation of advanced knowledge, skills, and ethical values in a post-licensure field Continuing Professional Development (CPD) - Answer Multidisciplinary field of study for assimilation into professional practice, self- directed research, and/or lifelong learning Cosmetics - Answer Substance or preparation intended to be placed in contact with the various external parts of the human body or with the teeth and the mucous membranes of the oral cavity Cosmetics - Answer For the purpose of cleaning them, perfuming them, changing their appearance and/or correcting body odor, and/or protecting the body or keeping them in good condition Counterfeit pharmaceutical products - Answer Do not contain the amounts as claimed; with wrong ingredients; without active ingredients; or with insufficient quantity of active ingredients Counterfeit pharmaceutical products - Answer Products that are deliberately and fraudulently mislabelled with respect to identify and/or source or with fake packaging, and can apply to both branded and generic products Dangerous drugs - Answer 1961 Single Convention on Narcotic Drugs, 1971 Single Convention on Psychotropic Substances, Annex of R.A.No. 9165 "Comprehensive Dangerous Drugs Act of 2002" Dispensing - Answer Sum of processes performed by a pharmacist Dispensing - Answer Reading, validating, and interpreting prescriptions; preparing; packaging; labelling; record keeping; dose calculations; and counseling or giving information, in relation to the sale or transfer of pharmaceutical products, with or without a prescription or medication order Drug Distributor/Importer/Exporter/Wholesaler - Answer Any drug or pharmaceutical establishment that imports or exports raw materials, active ingredients and/or pharmaceutical establishments or outlets Drug Information Services - Answer Any activity in response to a drug information request or query from healthcare professionals, organizations, committee, patients and other individuals Drug Information Services - Answer Providing carefully evaluated, evidence-based drug information and recommendation to support medication use practice, enhance quality of patient care, improve patient outcomes and ensure prudent use of resources Drugs - Answer Pharmaceutical products that pertain to chemical compounds or biological substances, other than food, intended for use in the treatment, prevention, or diagnosis of disease in humans or animals Drugstore - Answer Pharmaceutical outlets where registered drugs are dispensed directly to the end users or patients Emergency Cases - Answer Life-threatening situations where a patient needs immediate medical attention and treatment Expiration date - Answer End date Filling - Answer Act of dispensing Food/Dietary supplements - Answer Processed food products intended to supplement the diet Food/Dietary supplements - Answer Vitamins, minerals, herbs or other botanicals, amino acids, and dietary substances - Answer Generic name - Answer Scientifically and internationally recognized name of the active ingredients Good Clinical Pharmacy Practice (GCPP) - Answer International ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects Good Distribution Practice (GDP) - Answer Part of quality assurance which ensures that the quality of a pharmaceutical product is maintained through adequate control throughout the numerous activities which occur during the distribution process Good Laboratory Practice (GLP) - Answer Quality system concerned with the organizational process Good Laboratory Practice (GLP) - Answer Non-clinical health and environment safety studies are planned, performed, monitored, recorded, archived and reported Good Manufacturing Practice (GMP) - Answer System of quality assurance Good Manufacturing Practice (GMP) - Answer It is thus concerned with both manufacturing and quality control processes and procedures
Geschreven voor
- Instelling
- RA 10918
- Vak
- RA 10918
Documentinformatie
- Geüpload op
- 27 mei 2024
- Aantal pagina's
- 19
- Geschreven in
- 2023/2024
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
ra 10918
-
latest updated 2024
-
verified solution
-
graded
-
ra 10918 exam questions and answers